Cover Image
市場調查報告書

卵巢癌的預測:主要17大市場 (2015年∼2025年)

Ovarian Cancer Forecast in 17 Major Markets 2015-2025

出版商 Black Swan Analysis 商品編碼 339839
出版日期 內容資訊 英文 50 Pages
訂單完成後即時交付
價格
Back to Top
卵巢癌的預測:主要17大市場 (2015年∼2025年) Ovarian Cancer Forecast in 17 Major Markets 2015-2025
出版日期: 2015年09月01日 內容資訊: 英文 50 Pages
簡介

卵巢癌是在卵巢發病的癌症。異常細胞具有會轉移到生殖系統的能力,惡化期有可能會轉移到身體的其它部位。

本報告提供主要17大市場 (美國,法國,德國,義大利,西班牙,英國,巴西,日本,印度,澳洲,加拿大,墨西哥,土耳其,南非,沙烏地阿拉伯,阿根廷,俄羅斯) 的卵巢癌之目前患者數 (性別,年齡世代別) 調查分析,提供您目前得病率,加上疾病概要,危險因素,疾病診斷與預後,主要的症狀和併發症等系統性資訊。

圖表

簡介

病因

危險因素和預防

疾病診斷

變異:地區/各民族

疾病預後與臨床經過

疾病相關的主要併發症

患者數定量化手法

卵巢癌的得病率top line

卵巢癌的分期和惡性度

  • 卵巢癌的FIGO分期
  • CCI和卵巢癌
  • 卵巢癌的癌細胞病理組織

簡稱

相關出版

患者基群線上資料庫

患者基群產品

價格的線上資料·平台

參考文獻

附錄

目錄
Product Code: OVAR0010915

Ovarian Cancer begins in the ovaries, resulting from abnormal cells that have the ability to spread to other parts of the reproductive system and, in advanced stages, other parts of the body. The cause for Ovarian Cancer is not currently known, most DNA mutations for ovarian cancer are acquired genetic changes, however a link still has not yet been found to any environmental factors that may cause the mutation. This report provides the current incidence population for Ovarian Cancer across 17 Major Markets (USA, France, Germany, Italy, Spain, UK, Brazil, Japan, India, Australia, Canada, Mexico, Turkey, South Africa, Saudi Arabia, Argentina and Russia) split by gender and 5-year age cohort. Along with the current incidence, the report provides an overview of the stages, grades and associated Charlson Co-morbidity scoring of Ovarian Cancer. The report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.

Providing a value-added level of insight from the analysis team at Black Swan, several of the main symptoms and co-morbidities of Ovarian Cancer have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

Main symptoms and co-morbidities for Ovarian Cancer include:

  • Diabetes
  • Myocardial Infarct
  • Mild Liver Disease
  • Congestive Heart Failure
  • Dementia

This report is built using data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilises a combination of several world class sources that deliver the most up to date information form patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and analysis have been identified in the report.

Reason to buy

  • Able to quantify patient populations in global Ovarian Cancer's market to target the development of future products, pricing strategies and launch plans.
  • Gain further insight into the prevalence of the subdivided types of Ovarian Cancer and identify patient segments with high potential.
  • Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.
  • Provide a level of understanding on the impact from specific co-morbid conditions on Ovarian Cancer's prevalent population.
  • Identify sub-populations within Ovarian Cancer which require treatment.
  • Gain an understanding of the specific markets that have the largest number of Ovarian Cancer patients.

Coverage

US, UK, FR, DE, IT, ES, JP, BR, IN

Table of Contents

List of Tables and Figures

Introduction

Cause of the Disease

Risk Factors & Prevention

Diagnosis of the Disease

Variation by Geography/Ethnicity

Disease Prognosis & Clinical Course

Key Co-morbid Conditions Associated with the Disease

Methodology for Quantification of Patient Numbers

Top-Line Ovarian Cancer Incidence

Stages and Grading of Ovarian Cancer

  • FIGO Staging of Ovarian Cancer
  • Charlson Co-Morbidity Index and Ovarian Cancer
  • Histopathology of Tumour Cells in Ovarian Cancer

Abbreviations and Acronyms used in the Report

Other Black Swan Analysis Publications

Black Swan Analysis Online Patient-Based Databases

Patient-Based Offering

Online Pricing Data and Platforms

References

Appendix

List of Figures

  • Ovarian Cancer Incidence Rates for 2015

List of Tables

  • AJCC Tumour Grading Classification for Ovarian Cancer
  • FIGO Stage Descriptors of Ovarian Cancer
  • Charleston Co-morbidity Scoring Classification of Ovarian Cancer
  • Incidence of Ovarian Cancer, females (000s)
  • AJCC Stage at diagnosis for Ovarian cancer patients, females (000s)
  • FIGO staging in Ovarian Cancer patients, females (000s)
  • Stage I FIGO subtypes in Ovarian Cancer patients, females (000s)
  • Stage II FIGO subtypes in Ovarian Cancer patients, females (000s)
  • Stage III FIGO subtypes in Ovarian Cancer patients, females (000s)
  • Charleston Co-morbidity Scores for Ovarian Cancer patients, females (000s)
  • Major histopathological type in Ovarian Cancer patients, females (000s)
  • Adenocarcinoma subtypes in Ovarian Cancer patients, females (000s)
  • Abbreviations and Acronyms used in the Report
  • USA Incidence of Ovarian Cancer by 5-yr age cohort, females (000s)
  • France Incidence of Ovarian Cancer by 5-yr age cohort, females (000s)
  • Germany Incidence of Ovarian Cancer by 5-yr age cohort, females (000s)
  • Italy Incidence of Ovarian Cancer by 5-yr age cohort, females (000s)
  • Spain Incidence of Ovarian Cancer by 5-yr age cohort, females (000s)
  • United Kingdom Incidence of Ovarian Cancer by 5-yr age cohort, females (000s)
  • Brazil Incidence of Ovarian Cancer by 5-yr age cohort, females (000s)
  • Japan Incidence of Ovarian Cancer by 5-yr age cohort, females (000s)
  • India Incidence of Ovarian Cancer by 5-yr age cohort, females (000s)
  • Australia Incidence of Ovarian Cancer by 5-yr age cohort, females (000s)
  • Canada Incidence of Ovarian Cancer by 5-yr age cohort, females (000s)
  • Mexico Incidence of Ovarian Cancer by 5-yr age cohort, females (000s)
  • Turkey Incidence of Ovarian Cancer by 5-yr age cohort, females (000s)
  • South Africa Incidence of Ovarian Cancer by 5-yr age cohort, females (000s)
  • Saudi Arabia Incidence of Ovarian Cancer by 5-yr age cohort, females (000s)
  • Argentina Incidence of Ovarian Cancer by 5-yr age cohort, females (000s)
  • Russia Incidence of Ovarian Cancer by 5-yr age cohort, females (000s)
Back to Top